Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/22/2023 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 6k | $0.00 | $0 | | 05/22/2023 |
05/22/2023 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 12.1k | $25.74 | $310.3k | | 05/22/2023 |
05/18/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 3.5k | $189.87 | $655.8k | | 05/18/2023 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 30k | $30.09 | $902.7k | | 08/15/2022 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 3.7k | $63.86 | $234.4k | | 08/15/2022 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 715 | $232.81 | $166.5k | | 08/15/2022 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 3.9k | $231.65 | $892.5k | | 08/15/2022 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 16.2k | $230.71 | $3.7M | | 08/15/2022 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 11.6k | $229.93 | $2.7M | | 08/15/2022 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 1.2k | $228.33 | $278.1k | | 08/15/2022 |
08/15/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 98 | $226.16 | $22.2k | | 08/15/2022 |
06/01/2022 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 17.5k | $0.78 | $13.6k | | 06/01/2022 |
05/23/2022 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 6.4k | $0.00 | $0 | | 05/23/2022 |
05/23/2022 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 12.8k | $24.14 | $309.2k | | 05/23/2022 |
05/18/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 5.2k | $128.31 | $661.2k | | 05/18/2022 |
07/15/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4k | $171.95 | $693.3k | | 07/15/2021 |
06/08/2021 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 17.5k | $6.30 | $110.2k | | 06/08/2021 |
05/21/2021 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 3.4k | $0.00 | $0 | | 05/21/2021 |
05/21/2021 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 6.7k | $45.28 | $305.5k | | 05/21/2021 |
12/07/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Gift | Common Stock | 235.6k | $0.00 | $0 | | 12/07/2020 |
12/07/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Gift | Common Stock | 235.6k | $0.00 | $0 | by Trust | 12/07/2020 |
11/25/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 11.5k | $124.30 | $1.4M | | 11/25/2020 |
11/25/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 15.7k | $125.05 | $2M | | 11/25/2020 |
11/25/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 2.1k | $126.16 | $267.1k | | 11/25/2020 |
11/25/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 645 | $127.44 | $82.2k | | 11/25/2020 |
11/25/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 30k | $9.30 | $279k | | 11/25/2020 |
07/01/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4.6k | $148.77 | $681.5k | | 07/01/2020 |
06/11/2020 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 17.5k | $9.17 | $160.5k | | 06/11/2020 |
05/21/2020 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 24.8k | $37.06 | $920.9k | | 05/21/2020 |
05/21/2020 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 28.9k | $37.06 | $1.1M | | 05/21/2020 |
02/12/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 30k | $130.00 | $3.9M | | 02/12/2020 |
02/12/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Non-Qualified Stock Option (right to buy) | 15k | $9.14 | $137.1k | | 02/12/2020 |
02/12/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 15k | $15.82 | $237.3k | | 02/12/2020 |
11/18/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 5.6k | $91.17 | $506.8k | | 11/18/2019 |
11/18/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 8.6k | $91.97 | $793.8k | | 11/18/2019 |
|